Showing 10 of 10 recruiting trials for “digenic-alport-syndrome”
Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)
Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome
RecruitingNCT06526741 ↗
ASF Alport Patient Registry
RecruitingNCT05924347 ↗
Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development
RecruitingNCT05329935 ↗
Congenital Athymia Patient Registry
RecruitingNCT04947813 ↗
Genotype-Phenotype Correlations in Patients With Alport Syndrome
🏥 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2021View details ↗
Understanding of Psychotic Disorders in Children With 22q11.2DS
RecruitingNCT05927467 ↗
Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)
RecruitingNCT00556530 ↗
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
👨⚕️ Bernice E. Morrow, PhD, Albert Einstein College of Medicine📍 1 site📅 Started Jul 2016View details ↗
RecruitingNCT02378805 ↗
Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →